Skip to main content
. 2017 Aug 14;8(40):68381–68392. doi: 10.18632/oncotarget.20266

Figure 3. Associations of SLC2A1 or SLC2A2 expressions with overall survival in different tumor stages (I & II vs III & IV).

Figure 3

Overall survival analysis of HCC patients with respect to the expression levels of SLC2A1 or SLC2A2 was performed by Kaplan-Meier analysis. Expression levels are classified into low or high compared with the median (blue or red lines, respectively). (A, C) The curves were analyzed in Stage I & II group. (B, D) The curves were analyzed in Stage III & IV group.